Summary
Superoxide anion (O2 −) production and expression of cytochrome b558 by neutrophils were determined in 20 patients with myelodysplastic syndrome (MDS). The reduction of O2 − production was noted in eight of the 20 patients and an increase was noted in four patients when neutrophils were stimulated byn-formylmethionyl-leucyl-phenylalanine (FMLP), while a low level of O2 − production was found in 11 and an increase in six MDS patients when they were stimulated by phorbol myristate acetate (PMA). Among them, seven patients showed a decrease and four an increase in O2 − production on stimulation with either FMLP or PMA. Expression of cytochrome b 558 was found to be at low levels in patients who had neutrophils showing decreased O2 − production when stimulated with FMLP, indicating that decreased expression of cytochrome b558 might contribute to the impairment of O2 − production in some MDS patients. In this study, no significant differences in O2 − production were noted among subtypes of MDS; however, the patients who had received prednisolone showed lower levels of O2 − production than those who had not received prednisolone. Patients manifesting episodes of infection had reduced levels of O2 − production compared with those without infection. Furthermore, the fact that one patient who exhibited a marked reduction in neutrophil counts together with reduced O2 − production died of fatal infection, suggests that the determination of O2 − production, in combination with hematological features, may be of some help in predicting severe infection.
Similar content being viewed by others
References
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199
Boogerts MA, Nelissen V, Roelant C, Goosens W (1983) Blood neutrophil function in primary myelodysplastic syndromes. Br J Haematol 55: 217–227
Cech P, Markert M, Perrin LH (1983) Partial myeloperoxidase deficiency in preleukemia. Blut 47: 21–30
Cross RA, Jones OT, Harper AM, Segal AW (1981) Oxidationreduction properties of the cytochrome b found in the plasmamembrane fraction of human neutrophils. A possible oxidase in the respiratory burst. Biochem J 194: 599–606
Gahmberg CG, Andersson LC, Ruutu P, Timonen TT, Hänninen A, Vuopio P, de la Chapelle A (1979) Decrease of the major high-molecular-weight surface glycoprotein of human granulocytes in monosomy-7 associated with defective chemotaxis. Blood 54: 401–406
Goldstein IM, Roos D, Weissmann G (1976) Influence of corticosteroids on human polymorphonuclear leukocyte function in vitro: reduction of lysosomal enzyme release and Superoxide production. Inflammation 1: 305–315
Jacobs A (1985) Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol 38: 1201–1217
Klebanoff SJ, Clark RA (1978) The neutrophil: function and clinical disorders. North Holland, Amsterdam
Lehmeyer JE, Johnston RB (1978) Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue-bound IgG. Clin Immunol Immunopathol 9: 482–490
Martin S, Baldock SC, Ghoneim AT, Child JA (1983) Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders. J Clin Pathol 36: 1120–1128
Metcalf JA, Gallin JI, Nauseef WM, Root RK (1986) Laboratory manual of neutrophil function. Raven, New York, pp 2–7
Nelson DH, Ruhmann-Wennhold A (1978) Inhibition of leukocyte Superoxide anion production by cortisol administration to normal subjects. J Clin Endocrinol Metab 46: 702–705
Ojima T, Kuratsuji T, Shimizu S, Lee JY, Takahashi E, Takagi K (1984) Defective granulocyte function and chromosome abnormalities in hemopoietic dysplasia (in Japanese). Rinsho Ketsueki 25: 1204–1208
Ruutu P, Ruutu T, Vuopio P, Kosunen TU, de la Chapelle A (1977) Defective chemotaxis in monosomy-7. Nature 265: 146–147
Ruutu P, Ruutu T, Vuopio P, Kosunen TU, de la Chapelle A (1977) Function of neutrophils in preleukemia. Scand J Haematol 18: 317–325
Schreiner A, Sohlberg CO (1976) Neutrophil dysfunction and granulomatosis in the preleukemic state. Scand J Infect Dis 8: 53–55
Segal AW (1987) Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease. Nature 326: 88–91
Segal AW, Jones OT (1978) Novel cytochrome b system in phagocytic vacuoles from human granulocytes. Nature 276: 515–517
Segal AW, Jones OT, Webster D, Allison AC (1978) Absence of newly described cytochrome b from neutrophils of patients with chronic granulomatous disease. Lancet 2: 446–449
Shinagawa Y, Tanaka C, Taraoka A, Shinagawa Y (1966) A new cytochrome in neutrophilic granules of rabbit leucocyte. J Biochem 59: 622–624
Takahashi I, Inagaki N, Nakada H, Ohmoto E, Takeuchi M, Osada K, Matsuzaki T, Fukuda S, Uchida K, Kohi F, Yorimitsu S, Kimura I, Kitajima K, Sanada H (1988) Superoxide anion production by neutrophils in myelodysplastic syndromes (preleukemia). Acta Med Okayama 42: 15–19
Uike N, Hashimoto M, Takeichi N, Kozuru M (1989) Impaired Superoxide production by neutrophils in myelodysplastic syndrome: correlation with bone marrow karyotype (in Japanese). Rinsho Ketsueki 30: 830–834
Yuo A, Kitagawa S, Okabe T, Urabe A, Komatsu Y, Itoh S, Takaku F (1987) Recombinant human granulocyte colonystimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 70: 404–411
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Itoh, Y., Kuratsuji, T., Aizawa, S. et al. Superoxide anion production and expression of cytochrome b 558 by neutrophils are impaired in some patients with myelodysplastic syndrome. Ann Hematol 63, 270–275 (1991). https://doi.org/10.1007/BF01698377
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01698377